Intraarticular Ozone Therapy for Pain Control in Osteoarthritis of the Knee
NCT ID: NCT00832312
Last Updated: 2016-07-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE2
20 participants
INTERVENTIONAL
2009-08-31
2016-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effectiveness of Ultrasound Guided Ozone (O2-O3) Injection With Knee Osteoarthritis
NCT04830423
Intra Articular Injection of Ozone With Corticosteroids vs PRGF in Knee Osteoarthritis
NCT05837494
Evaluation of the Effect of Different Doses of Ozone Therapy on Pain and Function of Patients With Knee Osteoarthritis
NCT06088706
Effects of Platelet-Rich Plasma and Ozone Therapy in Knee Osteoarthritis
NCT06631456
Effect of Intraarticular Ozone, Prolotherapy or Dexmedetomidine in Pain Limitation in Knee Osteoarthritis
NCT06909305
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The present is the first of a series of studies planned to scientifically test the effectiveness of ozone as a main-stream therapy, introducing it to the Anglo-American literature. In this first study we will check whether intraarticular injections of Ozone into the knee joint are effective as a therapy for pain control in patients with osteoarthritis of the knee.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ozone-oxygen mixture
10 cc of an ozone-oxygen mixture with ozone concentration 10000 mcg/L (10 mcg/ml) injected into the knee joint
ozone-oxygen mixture
10 cc of an ozone-oxygen mixture with ozone concentration 10000 mcg/L (10 mcg/ml)
Saline
Injection of 1cc of saline into the knee joint
placebo (saline)
Injection of 1cc of saline into the knee joint
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ozone-oxygen mixture
10 cc of an ozone-oxygen mixture with ozone concentration 10000 mcg/L (10 mcg/ml)
placebo (saline)
Injection of 1cc of saline into the knee joint
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Cognitive impairment
* Adjacent osteomyelitis
* Bacteremia
* Hemarthrosis
* Impending (scheduled within days) joint replacement surgery
* Infectious arthritis
* Joint prosthesis
* Osteochondral fracture
* Periarticular cellulitis
* Poorly controlled diabetes mellitus
* Uncontrolled bleeding disorder or coagulopathy.
50 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ben-Gurion University of the Negev
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Howard Tandeter
POB 653 Beer Sheva
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Howard B Tandeter, MD
Role: PRINCIPAL_INVESTIGATOR
Ben GurionUniversity
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ben Gurion University
Beersheba, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20080780
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.